For the quarter ended September 2025, AMN Healthcare Services (AMN) reported revenue of $634.5 million, down 7.7% over the same period last year. EPS came in at $0.39, compared to $0.61 in the year-ago quarter.
The reported revenue represents a surprise of +3.15% over the Zacks Consensus Estimate of $615.14 million. With the consensus EPS estimate being $0.19, the EPS surprise was +105.26%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how AMN Healthcare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:View all Key Company Metrics for AMN Healthcare here>>>
Shares of AMN Healthcare have returned +7.1% over the past month versus the Zacks S&P 500 composite's +1.3% change. The stock currently has a Zacks Rank #5 (Strong Sell), indicating that it could underperform the broader market in the near term.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Aug-17 | |
| Aug-12 | |
| Aug-07 | |
| Aug-06 | |
| Aug-06 | |
| Jul-27 | |
| Jul-23 | |
| Jul-22 | |
| Jul-07 | |
| Jun-24 | |
| Jun-15 | |
| Jun-09 | |
| May-13 | |
| May-08 | |
| May-07 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite